Medscape2y
Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis
Background: Intrapartum antibiotic prophylaxis for neonatal group B streptococcal disease (GBS) effectively prevents disease among infants <7 days old, but there are no prevention strategies for ...
pharmaphorum2y
FDA gives Pfizer's Group B strep vaccine breakthrough status
Currently antibiotic prophylaxis administered to a woman during labour is the main means of preventing GBS disease in newborn infants, but only if the bacterium is detected during pregnancy.
Medscape29d
Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis
Nearly half of case-infants (47%) were exposed to intrapartum antibiotics, most often for GBS prophylaxis (56%), caesarian section prophylaxis (6%), or suspected chorioamnionitis (6%). In 127 ...